BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19107362)

  • 1. The effect of RhoC siRNA on the invasiveness and proliferation of human cervical cancer cell line SiHa cells.
    He X; Qian Y; Cai H; Wang Z
    J Huazhong Univ Sci Technolog Med Sci; 2008 Dec; 28(6):665-9. PubMed ID: 19107362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of Rab11 gene expression on the invasion and migration of cervical cancer cell line SiHa in hypoxia].
    Xu H; Yuan Y; Ji JY; Jiang Q; Niu LJ; Liu NL; Zhang LZ; Wang X
    Zhonghua Fu Chan Ke Za Zhi; 2016 Dec; 51(12):928-933. PubMed ID: 28057129
    [No Abstract]   [Full Text] [Related]  

  • 3. Silencing MTA1 by RNAi reverses adhesion, migration and invasiveness of cervical cancer cells (SiHa) via altered expression of p53, and E-cadherin/β-catenin complex.
    Rao Y; Wang H; Fan L; Chen G
    J Huazhong Univ Sci Technolog Med Sci; 2011 Feb; 31(1):1-9. PubMed ID: 21336715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RhoA and RhoC -siRNA inhibit the proliferation and invasiveness activity of human gastric carcinoma by Rho/PI3K/Akt pathway.
    Sun HW; Tong SL; He J; Wang Q; Zou L; Ma SJ; Tan HY; Luo JF; Wu HX
    World J Gastroenterol; 2007 Jul; 13(25):3517-22. PubMed ID: 17659701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RhoC mediates invasion and migration of CaSki cells through the Rho-associated serine-threonine protein kinase 1 signaling pathway.
    Chen R; Cheng Y; Zhang Y; Li Z; Geng L
    Int J Gynecol Cancer; 2014 Feb; 24(2):184-91. PubMed ID: 24457551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects and mechanism of RhoC downregulation in suppressing ovarian cancer stem cell proliferation, drug resistance, invasion and metastasis.
    Sang XB; Sun KX; Wang LL; Chen S; Wu DD; Zong ZH; Zhao Y
    Oncol Rep; 2016 Dec; 36(6):3267-3274. PubMed ID: 27748937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Trametenolic acid inhibits migration and invasion of hepatocellular carcinoma HepG2.2.15 cells via RhoC/ROCK1 pathway].
    Wan YL; Wang JZ; Yuan Y; Ye WY; Li HL; Zhang XL; Zhang HQ; Li LE
    Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(1):185-196. PubMed ID: 38403351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RhoC is essential for the metastasis of gastric cancer.
    Liu N; Zhang G; Bi F; Pan Y; Xue Y; Shi Y; Yao L; Zhao L; Zheng Y; Fan D
    J Mol Med (Berl); 2007 Oct; 85(10):1149-56. PubMed ID: 17549441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between MTA1 expression and invasive and metastatic ability of cervical cancer cell].
    Han XY; Qian HL; Yang JJ; Zhang XY; Fu M; Liang X; Lin C; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):678-83. PubMed ID: 22176993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
    Wei L; Qin XP; Zhao XX; Wang W
    Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
    Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H
    Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
    Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
    Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [FABP5 promotes cell growth, invasion and metastasis in cervical cancer].
    Zhan YZ; Liu F; Zhang Y; Mo XY; Cheng WD; Wang W
    Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):200-207. PubMed ID: 30917456
    [No Abstract]   [Full Text] [Related]  

  • 14. Notch1 regulates the functional contribution of RhoC to cervical carcinoma progression.
    Srivastava S; Ramdass B; Nagarajan S; Rehman M; Mukherjee G; Krishna S
    Br J Cancer; 2010 Jan; 102(1):196-205. PubMed ID: 19953094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of adenovirus mediated tandem expression of RhoA and RhoC shRNAs in HCT116 cells.
    Liu XP; Wang HB; Yang K; Sui AH; Shi Q; Qu S
    J Exp Clin Cancer Res; 2009 Apr; 28(1):52. PubMed ID: 19374769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.
    Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM
    Breast Cancer Res; 2007; 9(6):R76. PubMed ID: 17980029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells.
    Kaushal N; Durmaz YY; Bao L; Merajver SD; ElSayed ME
    Mol Pharm; 2015 Jul; 12(7):2406-17. PubMed ID: 26020100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. siRNA-TMEM98 inhibits the invasion and migration of lung cancer cells.
    Mao M; Chen J; Li X; Wu Z
    Int J Clin Exp Pathol; 2015; 8(12):15661-9. PubMed ID: 26884835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic inactivation of HOXD10 is associated with human colon cancer via inhibiting the RHOC/AKT/MAPK signaling pathway.
    Yuan YH; Wang HY; Lai Y; Zhong W; Liang WL; Yan FD; Yu Z; Chen JK; Lin Y
    Cell Commun Signal; 2019 Jan; 17(1):9. PubMed ID: 30683109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation of expression of RhoC with invasiveness of prostate cancer cell line PC-3M in vitro].
    Yuan Z; Su J; You JF; Wang JL; Cui XL; Zheng J
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):51-5. PubMed ID: 18346381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.